Fehnel S - Search Results

1

Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report.

Spiegel B, Camilleri M, Bolus R, Andresen V, Chey WD, Fehnel S, Mangel A, Talley NJ, Whitehead WE. Spiegel B, et al. Among authors: fehnel s. Gastroenterology. 2009 Dec;137(6):1944-53.e1-3. doi: 10.1053/j.gastro.2009.08.047. Epub 2009 Aug 23. Gastroenterology. 2009. PMID: 19706292 Free PMC article.

2

Global endpoints in functional gastrointestinal disease.

Mangel AW, Fehnel SE. Mangel AW, et al. Among authors: fehnel se. Aliment Pharmacol Ther. 2005 Dec;22(11-12):1162-3; author reply 1163-4. doi: 10.1111/j.1365-2036.2005.02708.x. Aliment Pharmacol Ther. 2005. PMID: 16305732 No abstract available.

3

Adequate relief in IBS treatment trials: corrections to errors stated by Whitehead et al.

Mangel AW, Fehnel S. Mangel AW, et al. Among authors: fehnel s. Am J Gastroenterol. 2006 Dec;101(12):2884-5; author reply 2885-7. doi: 10.1111/j.1572-0241.2006.00867_1.x. Am J Gastroenterol. 2006. PMID: 17227528 No abstract available.

4

Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints.

Camilleri M, Mangel AW, Fehnel SE, Drossman DA, Mayer EA, Talley NJ. Camilleri M, et al. Clin Gastroenterol Hepatol. 2007 May;5(5):534-40. doi: 10.1016/j.cgh.2007.03.004. Epub 2007 Apr 11. Clin Gastroenterol Hepatol. 2007. PMID: 17428741 Review.

5

Gastrointestinal side effects in chronic opioid users: results from a population-based survey.

Cook SF, Lanza L, Zhou X, Sweeney CT, Goss D, Hollis K, Mangel AW, Fehnel SE. Cook SF, et al. Among authors: fehnel se. Aliment Pharmacol Ther. 2008 Jun;27(12):1224-32. doi: 10.1111/j.1365-2036.2008.03689.x. Epub 2008 Mar 21. Aliment Pharmacol Ther. 2008. PMID: 18363893

6

Design of treatment trials in irritable bowel syndrome: opioid agonists and atypical benzodiazepine antagonists.

Mangel AW, Fehnel SE. Mangel AW, et al. Among authors: fehnel se. Neurogastroenterol Motil. 2008 Oct;20(10):1086-93. doi: 10.1111/j.1365-2982.2008.01198.x. Neurogastroenterol Motil. 2008. PMID: 18826559 Review.

7

End points in irritable bowel syndrome.

Mangel AW, Fehnel SE. Mangel AW, et al. Expert Rev Gastroenterol Hepatol. 2011 Jun;5(3):293-5. doi: 10.1586/egh.11.13. Expert Rev Gastroenterol Hepatol. 2011. PMID: 21651345 No abstract available.

8

Assessment of treatment response in chronic constipation clinical trials.

Ervin CM, Fehnel SE, Baird MJ, Carson RT, Johnston JM, Shiff SJ, Kurtz CB, Mangel AW. Ervin CM, et al. Clin Exp Gastroenterol. 2014 Jun 3;7:191-8. doi: 10.2147/CEG.S58321. eCollection 2014. Clin Exp Gastroenterol. 2014. PMID: 24940076 Free PMC article.

9

Urgency as an Endpoint in Irritable Bowel Syndrome.

Mangel AW, Wang J, Sherrill B, Gnanasakthy A, Ervin C, Fehnel SE. Mangel AW, et al. Gastroenterology Res. 2011 Feb;4(1):9-12. doi: 10.4021/gr283e. Epub 2011 Jan 20. Gastroenterology Res. 2011. PMID: 27957006 Free PMC article.

10

Psychometric validation of symptom severity measures in irritable bowel syndrome with constipation.

Williams VS, Nelson LM, Fehnel SE, MacDougall J, Carson RT, Tourkodimitris S, Kurtz C, Baird MJ, Johnston JM. Williams VS, et al. Among authors: fehnel se. Aliment Pharmacol Ther. 2014 Aug;40(3):298-308. doi: 10.1111/apt.12830. Epub 2014 Jun 18. Aliment Pharmacol Ther. 2014. PMID: 24943204 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters